ArticleExpert review of pharmacoeconomics & outcomes research2012
The use of age-period-cohort analysis to determine the impact of economic development on COPD mortality in Hong Kong.
Article in Expert review of pharmacoeconomics & outcomes research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Spatiotemporal Scan and Age-Period-Cohort Analysis of Hepatitis C Virus in Henan, China: 2005-2012.PloS one · 2015Article
Corrections and comments
- Comment on
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic obstructive pulmonary disease (COPD) is a leading cause of death worldwide. The rising trend in COPD-related mortality can be linked to aging populations and trends in risk factors possibly correlated with macroeconomic development. An age-period-cohort analysis of data on a recently developed economy, Hong Kong, is able to decompose sex-specific COPD mortality rates into age, period and birth-cohort effects to examine the possible impacts of defined macro-level events. The findings of this study corroborate the relationship between COPD incidence and an aging population, shows strong evidence for declining COPD mortality among generations raised in a more economically developed environment, but, possibly due to modeling limitations, only mixed results regarding the impact of changes in air quality.
Identifiers
22280192What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.